$XXII Cashflow Statement | Understand Stock

$XXII

$0.10 -$0.00 (3.34%) After hours

$XXII Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated statements of cash flows

In millions of USD; shares in millions, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 1 months to Feb 15, 2024	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Cash flows from operating activities:
Net loss
Adjustments to reconcile net loss to cash used in operating activities:
Amortization of license fees
Amortization of ROU assets
Impairment of goodwill and long-lived assets
Impairment of long-lived assets - held for sale
Impairment of long-lived assets
Amortization and depreciation
Amortization of right-of-use assets
Amortization of inventory step-up
Unrealized loss on investment
GVB fire write-offs
Realized loss on short-term investment securities
Change in allowance for doubtful accounts
Other non-cash gains
Provision for credit losses
(Gain) loss on sale or disposal of property, plant, and equipment
Realized loss (gain) on Panacea investment
Accretion of non-cash interest expense (income), net
Debt related charges included in interest expense
Equity-based compensation
Change in fair value of warrant liabilities
Change in fair value of derivative liability
Deferred income taxes
Change in inventory reserves
Changes in operating assets and liabilities:
Accounts receivable
Inventories
Prepaid expenses and other assets
Operating lease obligations
Accounts payable
Accrued expenses
Accrued expenses and other current liabilities
Accrued excise taxes and fees
Accrued severance
Contract liabilities
Accrued payroll
Other liabilities

Net cash used in operating activities
Cash flows from investing activities:
Acquisition of patents, trademarks, and licenses
Acquisition of property, plant and equipment
Proceeds from the sale of machinery and equipment
Proceeds from the sale of property, plant and equipment
Acquisition, net of cash acquired
Investment in Change Agronomy Ltd.
Sales and maturities of short-term investment securities
Purchase of short-term investment securities
Issuance of 2025 GVB promissory note
Payments received from 2025 GVB promissory note
Net cash used in investing activities

Cash flows from financing activities:
Payments on notes payable
Proceeds from note payable issuance
Proceeds from issuance of notes payable
Other financing activities
Payments of penalties from long-term debt
Payments of long-term debt
Net proceeds from option exercise
Net proceeds from Series A convertible preferred stock
Payments of deferred offering costs
Taxes paid related to net share settlement of RSUs
Net cash provided by financing activities

Net increase in cash and cash equivalents
Cash and cash equivalents - beginning of year
Cash and cash equivalents - end of year
Supplemental disclosures of cash flow information:
Net cash paid for:
Cash paid during the period for interest
Cash (received) paid during the period for income taxes
Non-cash transactions:
Patent and trademark additions included in accounts payable
Property, plant and equipment additions included in accounts payable
Capital expenditures incurred but not yet paid
Deemed dividends
Stock issued in connection with acquisition
Stock issued in connection with settled indebtedness
Non-cash licensing arrangement
Right-of-use assets and corresponding operating lease obligations
Patent and trademark additions included in accrued expenses
Panacea investment conversion
Stock issued for extinguishment of Subordinated Note
Payment of 2023 GVB promissory note
Payment of debt issuance costs
Equity conversion of Senior Secured Credit Facility
Conversion option remeasurement

Comments